`
`KeyCite Yellow Flag - Negative Treatment
`Distinguished by
` Shire LLC v Amneal Pharmaceuticals, LLC, D N J ,
`June 23, 2014
`
`
`
`534 Fed.Appx. 999 (Mem)
`This case was not selected for
`publication in the Federal Reporter.
`Not for Publication in West's Federal Reporter.
`See Fed. Rule of Appellate Procedure 32.1
`generally governing citation of judicial
`decisions issued on or after Jan. 1, 2007. See
`also Federal Circuit Rule 32.1 and Federal
`Circuit Local Rule 32.1. (Find CTAF Rule 32.1)
`United States Court of Appeals,
`Federal Circuit.
`
`Attorneys and Law Firms
`
`Theresa M. Gillis, Mayer Brown LLP, of New York, NY,
`argued for plaintiff-appellee. With her on the brief were John
`J. Molenda. Of counsel on the brief were Thomas W. Jenkins
`and Erick J. Palmer, of Chicago, IL.
`
`Jeffrey J. Toney, Kasowitz, Benson Torres & Friedman LLP,
`of Atlanta, GA, argued for defendants-appellants. With him
`on the brief were Jonathan K. Waldrop and Darcey L. Jones.
`Of counsel on the brief was Norman E.B. Minnear, of New
`York, NY. Of counsel was Parker C. Ankrum, of Redwood,
`CA.
`
`DYK, O'MALLEY, and WALLACH, Circuit Judges.
`
`VALEANT INTERNATIONAL
`BERMUDA, Plaintiff–Appellee,
`v.
`ACTAVIS, INC., Watson Laboratories, Inc.-Florida,
`and Actavis Pharma, Inc., Defendants–Appellants.
`
`JUDGMENT
`
`PER CURIAM.
`
`THIS CAUSE having been heard and considered, it is
`
`Nos. 2012–1117, 2012–1307.
`|
`Oct. 16, 2013.
`
`ORDERED and ADJUDGED:
`
`AFFIRMED. See Fed. Cir. R. 36.
`
`Appeals from the United States District Court for the
`Southern District of Florida in No. 10–CV–20526.
`
`All Citations
`
`534 Fed.Appx. 999 (Mem)
`
`End of Document
`
`© 2016 Thomson Reuters. No claim to original U.S. Government Works.
`
` © 2016 Thomson Reuters. No claim to original U.S. Government Works.
`
`1
`
`Page 1 of 1
`
`Grunenthal GmbH Exhibit 2005
`Rosellini v. Grunenthal GmbH
`IPR2016-00471